News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
685,491 Results
Type
Article (39045)
Company Profile (279)
Press Release (646167)
Section
Business (203862)
Career Advice (1989)
Deals (35362)
Drug Delivery (85)
Drug Development (80806)
Employer Resources (168)
FDA (16086)
Job Trends (14804)
News (344543)
Policy (32437)
Tag
Academia (2530)
Alliances (49077)
Alzheimer's disease (1228)
Approvals (16018)
Artificial intelligence (130)
Bankruptcy (352)
Best Places to Work (11534)
Biotechnology (200)
Breast cancer (119)
Cancer (1077)
Cardiovascular disease (97)
Career advice (1659)
Cell therapy (231)
Clinical research (64236)
Collaboration (384)
Compensation (197)
COVID-19 (2532)
C-suite (94)
Data (1119)
Diabetes (152)
Diagnostics (6138)
Earnings (84815)
Employer resources (146)
Events (109447)
Executive appointments (307)
FDA (16617)
Funding (346)
Gene therapy (176)
GLP-1 (574)
Government (4324)
Healthcare (18668)
Infectious disease (2616)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16295)
Job creations (3623)
Job search strategy (1417)
Layoffs (412)
Legal (7853)
Lung cancer (170)
Manufacturing (176)
Medical device (13174)
Medtech (13179)
Mergers & acquisitions (19138)
Metabolic disorders (398)
Neuroscience (1503)
NextGen Class of 2024 (6500)
Non-profit (4464)
Northern California (1474)
Obesity (228)
Opinion (179)
Patents (101)
People (56262)
Phase I (19949)
Phase II (28296)
Phase III (21097)
Pipeline (454)
Postmarket research (2553)
Preclinical (8487)
Radiopharmaceuticals (235)
Rare diseases (217)
Real estate (5890)
Regulatory (21518)
Research institute (2308)
Resumes & cover letters (349)
Southern California (1297)
Startups (3561)
United States (13377)
Vaccines (549)
Weight loss (166)
Date
Today (133)
Last 7 days (788)
Last 30 days (3731)
Last 365 days (35577)
2024 (32589)
2023 (40074)
2022 (51175)
2021 (55715)
2020 (54091)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (192)
Asia (37116)
Australia (6057)
California (3307)
Canada (1282)
China (247)
Colorado (143)
Connecticut (150)
Europe (79492)
Florida (455)
Georgia (116)
Illinois (338)
Indiana (195)
Kansas (96)
Maryland (573)
Massachusetts (2587)
Michigan (157)
Minnesota (271)
New Jersey (947)
New York (950)
North Carolina (696)
Northern California (1474)
Ohio (138)
Pennsylvania (839)
South America (1091)
Southern California (1297)
Texas (458)
Utah (90)
Washington State (357)
685,491 Results for "medicago inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Business
Medicago announces the appointment of Toshifumi Tada as President and CEO
Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, announced the appointment of Toshifumi Tada as President and chief executive officer, effective on May 1, 2022.
April 28, 2022
·
2 min read
Policy
Health Canada authorizes Medicago COVID-19 vaccine for adults 18 to 64 years of age
Health Canada authorized Medicago’s Covifenz COVID-19 vaccine for the prevention of COVID-19 in adults 18 to 64 years of age.
February 24, 2022
·
2 min read
Drug Development
Medicago submits Phase 3 data to Health Canada for its plant-based COVID-19 vaccine candidate
Medicago, a biopharmaceutical company headquartered in Quebec City, is pleased to announce submission of the positive Phase 3 data for regulatory review by Health Canada as part of the New Drug Submission for COVID (NDS-CV) rolling review for Medicago’s COVID-19 vaccine candidate combined with GSK’s pandemic adjuvant.
December 16, 2021
·
3 min read
Drug Development
Medicago announces publication of Phase 3 COVID-19 vaccine study results in New England Journal of Medicine
Medicago today announced the publication of the results from the Phase 3 study of COVIFENZ®, COVID-19 vaccine (plant-based virus-like particles [VLP], recombinant, adjuvanted), in the New England Journal of Medicine (NEJM).
May 5, 2022
·
2 min read
Drug Development
Clinical Catch-Up: Pfizer’s Paxlovid Gaff, a Win for Medicago-GSK’s Vaccine
Pfizer’s Paxlovid racks up a rare trial miss, Medicago and GSK publish positive data for their plant-based particle vaccine and Rhythm Pharmaceuticals touts strong potential in Bardet-Biedl Syndrome.
May 6, 2022
·
9 min read
·
Mark Terry
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Job Trends
Medicago and GSK Announce the Approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 Vaccine
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health Canada has granted approval for COVIFENZ®, COVID-19 vaccine, (plant-based virus-like particles [VLP], recombinant, adjuvanted).
February 24, 2022
·
5 min read
Job Trends
Medicago and GSK announce the approval by Health Canada of COVIFENZ, an Adjuvanted Plant-Based COVID-19 Vaccine
Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health Canada has granted approval for COVIFENZ®, COVID-19 vaccine, (plant-based virus-like particles [VLP], recombinant, adjuvanted).
February 24, 2022
·
4 min read
Press Releases
Boston Scientific Closes Acquisition of Axonics, Inc.
November 15, 2024
·
5 min read
1 of 68,550
Next
